
MTD does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for MTD and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MTD and 80,000+ other tickers.
See exactly how MTD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MTD and 80,000+ other tickers.
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances…

California State Teachers Retirement System grew its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 114,807.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,100,865 shares of the medical instruments supplier's stock after buying an additional 35,070,318 shares during

Bank of Nova Scotia purchased a new stake in Mettler-Toledo International, Inc. (NYSE: MTD) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,306 shares of the medical instruments supplier's stock, valued at approximately $4,223,000. A number of other hedge funds have also

Mettler-Toledo (MTD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The transaction involved the disposition of 417 shares valued at $601,000, based on a weighted-average execution price of $1,440.41 per share. Salice maintains a significant interest through indirect holdings in SRB Investments LLC and Teaghlach LLC.

This executive disposed of 240 shares for about $343,000 on August 3. The sale was executed immediately following the exercise of 240 options with an exercise price of $720.81 per share.